PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

ECT sessions shape depression treatment outcomes

New review reveals optimal timing for electroconvulsive therapy transitions

2025-06-03
(Press-News.org) HEFEI, Anhui, China, 3 June 2025 – In a comprehensive peer-reviewed Genomic Press Thought Leaders Invited Review, researchers have unveiled critical insights into how the number of electroconvulsive therapy (ECT) sessions influences treatment outcomes for depression, potentially transforming clinical decision-making for one of psychiatry's most effective yet controversial treatments.

The review, published in Brain Medicine, synthesizes decades of research to address a fundamental question that has long puzzled clinicians: How many ECT sessions are optimal for treating severe depression while minimizing cognitive side effects?

"ECT is like a powerful medication where dosing matters tremendously," explains Professor Yanghua Tian from Anhui Medical University, the study's corresponding author. "Our analysis reveals that the relationship between session number and outcomes is far more nuanced than previously understood."

Early Gains, Diminishing Returns

The research team's analysis uncovered a striking pattern in treatment response. Patients typically experience substantial improvement within the first three ECT sessions, with depression scores dropping by approximately 26% after the first session and nearly 50% by the third. However, this rapid early response gives way to a plateau effect, raising questions about the optimal treatment duration.

"We found that some patients achieve remission after just four sessions, while others may receive 12 or more with minimal additional benefit," notes Dr. Yang Ji, the study's first author. "This variability suggests we need a more personalized approach."

The review identified distinct response trajectories, with approximately 25% of patients showing rapid improvement, 30% demonstrating moderate gains, and troublingly, about 13% experiencing minimal benefit despite continued treatment. Could genetic markers or brain imaging help predict which patients will respond quickly versus those who might need alternative approaches?

The Cognitive Cost of Treatment

Perhaps most significantly, the review highlights the accumulating cognitive burden associated with extended ECT courses. While early sessions produce dramatic symptom relief, each additional session increases the risk of memory impairment – a trade-off that has long troubled both patients and physicians.

The researchers found that cognitive deficits emerge as early as the second session and tend to accumulate throughout treatment. "It's a delicate balance," Professor Tian explains. "We must weigh the benefits of continued sessions against the mounting cognitive costs."

Intriguingly, seizure duration – long considered a marker of treatment adequacy – shows a progressive decline across sessions. This phenomenon raises fundamental questions about the mechanisms underlying ECT's effectiveness. Are shorter seizures in later sessions a sign of treatment resistance, or do they reflect the brain's adaptive response?

Biomarkers Paint a Dynamic Picture

The review's examination of neurobiological changes during ECT reveals a complex cascade of effects. Brain imaging studies show progressive increases in hippocampal volume – a region critical for memory formation – alongside changes in neurotransmitter systems and inflammatory markers.

"We're seeing the brain essentially rewiring itself session by session," Dr. Ji notes. "Understanding these dynamics could help us identify the sweet spot where therapeutic benefits are maximized before cognitive effects become problematic."

Blood-based biomarkers, including brain-derived neurotrophic factor (BDNF) and cortisol, show transient spikes after individual sessions but return to baseline over the treatment course. These patterns suggest that the brain's response to ECT is highly dynamic, adapting with each successive session. Could monitoring these biomarkers in real-time help clinicians make more informed decisions about when to stop or modify treatment?

A Revolutionary Sequential Strategy

Based on their comprehensive analysis, the researchers propose a paradigm-shifting approach: a response-guided sequential treatment strategy. Rather than adhering to fixed session numbers, this framework advocates for transitioning to alternative treatments once optimal ECT benefits are achieved.

"Think of it as an relay race where ECT runs the first leg," Professor Tian explains. "Once it's delivered its maximum benefit – often within 3-6 sessions for responders – we pass the baton to safer maintenance therapies."

The strategy categorizes patients into three groups based on their response patterns:

Rapid responders who achieve remission quickly may transition to non-invasive brain stimulation or psychotherapy Slow responders might benefit from augmentation strategies like ketamine Non-responders could be switched to alternative treatments entirely This approach addresses a critical gap in current practice, where session numbers often reflect institutional protocols rather than individual patient needs. How might implementing such personalized protocols change treatment outcomes on a population level?

Implications for Clinical Practice

The review's findings challenge the traditional "more is better" approach to ECT administration. Current guidelines recommending 6-12 sessions may need revision in light of evidence showing early response patterns and accumulating cognitive burden.

"We're not suggesting ECT is any less valuable," Dr. Ji emphasizes. "Rather, we're proposing smarter utilization that maximizes benefits while minimizing risks."

The researchers note that implementing response-guided protocols would require closer monitoring of both symptoms and cognitive function throughout treatment. This could involve regular assessments using validated scales and potentially incorporating novel biomarkers as they become clinically available.

Several questions emerge from this new framework: How would early ECT termination affect long-term relapse rates? Could combination therapies initiated after fewer ECT sessions prove more effective than extended ECT courses alone? What role might emerging technologies like transcranial magnetic stimulation play in these sequential protocols?

Future Directions

The review highlights numerous avenues for future research. Developing predictive algorithms that integrate clinical features, biomarkers, and early response patterns could help identify optimal session numbers for individual patients. Additionally, comparative studies of sequential treatment strategies versus traditional extended ECT courses are urgently needed.

"We're at a pivotal moment in ECT's evolution," Professor Tian concludes. "By embracing precision medicine principles, we can preserve ECT's remarkable efficacy while dramatically reducing its cognitive burden."

The implications extend beyond individual patient care. Healthcare systems struggling with ECT capacity could potentially treat more patients if average session numbers decrease without compromising outcomes. Moreover, patients hesitant about ECT due to cognitive concerns might be more willing to consider treatment if they knew it could be limited to just a few sessions.

As mental health systems worldwide grapple with rising depression rates, optimizing our most effective treatments becomes increasingly critical. This comprehensive review provides a roadmap for transforming ECT from a one-size-fits-all intervention to a precision tool in the psychiatric arsenal. Will this response-guided approach become the new standard of care, finally resolving ECT's efficacy-cognition dilemma?

The peer-reviewed article in Brain Medicine titled "Rethinking the impact and management of electroconvulsive therapy session number in depression," is freely available via Open Access on 3 June 2025 in Brain Medicine at the following hyperlink: https://doi.org/10.61373/bm025i.0053.

About Brain Medicine: Brain Medicine (ISSN: 2997-2639, online and 2997-2647, print) is a peer-reviewed medical research journal published by Genomic Press, New York. Brain Medicine is a new home for the cross-disciplinary pathway from innovation in fundamental neuroscience to translational initiatives in brain medicine. The journal's scope includes the underlying science, causes, outcomes, treatments, and societal impact of brain disorders, across all clinical disciplines and their interface.

Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/

Our full website is at: https://genomicpress.kglmeridian.com/

END


ELSE PRESS RELEASES FROM THIS DATE:

Psilocybin enters gastroenterology: First-ever psychedelic study targets treatment-resistant IBS

2025-06-03
BOSTON, Massachusetts, USA, 3 June 2025 – In a comprehensive Genomic Press Interview published today, Dr. Erin E. Mauney reveals how her pioneering research brings psychedelic medicine into gastroenterology for the first time, potentially transforming treatment for millions suffering from intractable irritable bowel syndrome (IBS). The assistant professor of pediatrics at Tufts University, who maintains a research appointment at Massachusetts General Hospital, leads the first clinical trial examining psilocybin's effects on treatment-resistant IBS. Her work addresses a critical gap in medicine: the substantial population ...

Renowned psychiatrist illuminates biological roots of mental illness through pioneering research

2025-06-03
MILANO, Italy, 3 June 2025 – In a comprehensive Genomic Press Interview published in Brain Medicine, Professor Francesco Benedetti shares his transformative journey from confronting childhood awareness of mental illness to becoming a leading figure in psychiatric research. As founder and leader of the Psychiatry & Clinical Psychobiology research unit at IRCCS Ospedale San Raffaele, Dr. Benedetti has dedicated decades to reclaiming psychiatry's rightful place within medical science. Professor ...

Ancient collagen can help identify a “wombat the size of a hippo” in the fossil record

2025-06-03
What happened to all the megafauna? From moas to mammoths, many large animals went extinct between 50 and 10,000 years ago. Learning why could provide crucial evidence about prehistoric ecosystems and help us understand future potential extinctions. But surviving fossils are often too fragmented to determine the original species, and DNA is not always recoverable, especially in hot or damp environments. Now scientists have isolated collagen peptide markers which allow them to identify three key megafauna ...

Being in nature can help people with chronic back pain manage their condition

2025-06-03
ing time in or around nature can provide people suffering from chronic lower back pain with a degree of escapism that helps them better manage their physical discomfort, a new study has shown. The research, published in The Journal of Pain, is the first of its kind to ask people experiencing chronic lower back pain – in some cases for almost 40 years – about the role nature plays in any coping strategies they employ to help manage their condition. The researchers found that people able to get out in nature said it enabled them to connect with ...

Eating rate has sustained effects on energy intake from ultra-processed diets, new study reveals

2025-06-03
Brussels, Belgium — 2 June 2025 — A randomized controlled trial (RCT) carried out by researchers from Wageningen University, the Netherlands, has provided new evidence that texture-derived differences in meal eating rate influence energy intake from diets composed of ultra-processed foods (UPFs). Over a 14-day period, participants consuming a UPF diet with textures that reduced their eating rate, had an average energy intake reduction of 369 kcal per day, compared to when they followed a 14-day UPF diet with textures that promoted a faster ...

Rise in expectant mothers in UK with autoimmune diseases since millennium

2025-06-02
Thousands more UK women who are having children have been diagnosed with an autoimmune condition now compared to the beginning of the millennium. In a paper published in Lancet Rheumatology today, researchers involved in the MuM-PreDiCT project run by the University of Birmingham and funded by the Medical Research Council have found that there has been increase by 4.7% in expectant mothers beginning pregnancy with autoimmune conditions. Analysis of electronic healthcare records (CPRD) taken from 2000-2021 found that there was a ...

Majority of riders and drivers in UK 'gig economy' suffer anxiety over ratings and pay, study suggests

2025-06-02
Some two-thirds of riders and drivers for food delivery and ride-hailing apps in the UK may work in fear of “unfair feedback” and experience anxiety over sudden changes to working hours, a new survey study led by the University of Cambridge suggests.* Three-quarters of riders and drivers in the study report anxiety over potential for income to drop, with over half (51%) saying they risk health and safety while working. Some 42% of delivery and driver gig workers say they suffer physical pain resulting from work. Riders ...

Virginia Tech researchers develop recyclable, healable electronics

2025-06-02
Between upgrades and breakdowns to cellphones, tablets, laptops, and appliances, so many electronics are getting tossed in the trash that they've taken on a name of their own: e-waste. According to a 2024 report issued by the United Nations, the amount of e-waste worldwide has almost doubled in the past 12 years, from 34 billion to 62 billion kilograms — the equivalent of 1.55 million shipping trucks — and it's estimated to hit 82 billion kilograms by 2030. Just 13.8 billion kilograms — about 20 percent of the total — is expected to be recycled, a number ...

Cognitive outcomes similar after noncardiac surgery whether perioperative hypotension- or hypertension-avoidance strategies employed

2025-06-02
Embargoed for release until 5:00 p.m. ET on Monday 2 June 2025    Follow @Annalsofim on X, Facebook, Instagram, threads, and Linkedin         Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.    ----------------------------       Cognitive ...

Research spotlight: regional disparities in opioid overdose mortality persist despite national decline

2025-06-02
Sarah Wakeman, MD, Senior Medical Director for Substance Use Disorder at Mass General Brigham, is the co-senior author and Will Oles, BS, of Harvard Medical School, is a corresponding author of a paper published in the Journal of General Internal Medicine, “Geographic Trends in Opioid and Polysubstance Overdose Deaths in the US, 2014-2023.”  Q: How would you summarize your study for a lay audience?  In May 2024, the Centers for Disease Control (CDC) announced a national decline in the ...

LAST 30 PRESS RELEASES:

Smart amplifier enabler for more qubits in future quantum computers

Following the tracks of an extremely adaptive bacterium

New ‘designer drugs’ pose growing threat to road safety in the US

Tackling depressive symptoms in high school students by honing emotional and social skills

One in five US foods and drinks contain synthetic dyes, study shows

One in five packaged foods and drinks sold in the United States contains synthetic dyes, study shows

Large global study links severe bleeding after childbirth to increased risk of cardiovascular disease

Breaking the silence about men breaking bones

More sex, less pain and irritation for perimenopausal and postmenopausal women

New review highlights histone and non-histone lysine lactylation: From molecular mechanisms to therapeutic frontiers

Boson sampling finds first practical applications in quantum AI

Add a twist to π-molecules! A new design strategy for organic semiconductor materials

Bushfire evacuation simulator wins prestigious US prize

Desert lichen offers new evidence for the possibility of life on other planets

Researchers reveal how brain amplifies perception of pain from multiple sources

The first “SpongeBooster of the Year” award celebrates efforts in wetland restoration

AI innovation at UBC Okanagan helps shipping ports see what’s coming—literally

Autoimmune disease linked to doubling in depression, anxiety, bipolar risks

Emotional demands and confrontation in person-contact roles linked to heightened type 2 diabetes risk

UK annual cost of dog walkers’ hand/wrist injuries estimated to top £23 million

The Lancet: Life-saving childhood vaccination coverage has stalled in recent decades, leaving millions of children at risk for deadly diseases

MD Anderson achieves sixth Magnet designation in recognition of nursing excellence

A unified theory of the mind

UTA powers smarter microgrids with new converter tech

US$53,000 essay competition asks: "How Quantum is Life?"

New combination therapy for rheumatoid arthritis: Targeting M6A methylation pathways

Editorial for the special issue on carbon capture, utilization, and storage

'A more versatile and powerful foundation for future photonic technologies'

World’s soft coral diversity retains signature of an ancient, vanished sea

Scientists use gene editing to correct harmful mitochondrial mutations in human cells

[Press-News.org] ECT sessions shape depression treatment outcomes
New review reveals optimal timing for electroconvulsive therapy transitions